News

The final day of the 84th ADA Scientific Sessions has arrived. In our final Newsflash episode, Alice Cheng reviews major advances and discoveries in diabetes in the year gone by.

Incretin-based therapies are our focus in the Day 3 Newsflash from the 84th ADA Scientific Sessions. Ildiko Lingvay discusses their role in preventing the progression from prediabetes to diabetes. Michael Na...

A priority to focus on in people with newly diagnosed type 2 diabetes is remission, says Roy Taylor in the Newsflash from Day 2 of the ADA Scientific Sessions, emphasising the current international consensus.

The EASD e-Learning Newsflash is back, bringing you highlights from the 84th ADA Scientific Session.

Challenges for people with t1d doing sports and access to diabetes tech in lower income countries were some of the focus topics on the final day of ATTD2024. Julia Mader sums up her impressions from the conf...

We focus on Chantal Mathieu’s update on CGM derived data in weekly insulins in our newsflash from #ATTD2024 Day 3. Another standout moment for us was the EUDF joint session. It explored how artificial ...

Day 2 of ATTD 2024 came with updates on hypoglycaemia with Prof Pratik Choudhary and the unveiling of new monitoring guidance for presymptomatic type 1 diabetes with Co-Ch...

Highlights from Day1 of the 17th Conference on Advanced Technologies and Treatments for Diabetes with Prof Melanie Davies and Renza Scibilia.

‘Epidemiologic trends and disparities in diabetes risk factors among LGBTQ+ populations’ was the title of a presentation at the 59th Annual Meeting of the EASD and it highlighted the need for mor...

There is increasing interest in the role of the microbiome in many areas of medicine, including diabetes, in the hope of discovering novel therapeutic applications. A symposium at the 59th Annual Meeting of ...

With its comprehensively revised, reorganised and updated course on SGLT-2 inhibitors, launched today, EASD e-Learning signals a new phase in the learning platform’s development.

A new study reported in Diabetologia looks at the risk factors for developing diabetes among a cohort of pregnant women after giving birth. The research shows that decline in beta cell function is ranked as ...

Recent research suggests that there is much more to obesity than elevated body mass index. The latest findings on the role of liver fat and metabolically healthy obesity were under discussion at the 59th Ann...

The benefits of SGLT-2 inhibitors for people with type 2 diabetes and chronic kidney disease (CKD) have been amply demonstrated in recent years. So is it time to prescribe them to all those who have both con...

The latest research into hypoglycaemia was under discussion at the 59th Annual Meeting of the EASD. The ‘To hell with the hypo’ session covered topics ranging from a tool to predict nocturnal hyp...

Disparities in health burdens were explored at the American Diabetes Association’s 83rd Scientific Sessions. Lisa Buckingham reports. 

What are the barriers to technology use in primary care and how can we overcome them? This question was addressed at the American Diabetes Association’s 83rd Scientific Sessions. Lisa Buckingham report...

As research increasingly focuses on the early stages of type 1 diabetes, a presentation at the American Diabetes Association’s 83rd Scientific Sessions covered the emerging data on the potential of phy...

Intermittent fasting (IF) has gained popularity as a way of losing weight and improving cardiometabolic health. A debate on whether the window for eating within an IF regime is best timed early or late in th...

With an ageing population, it’s increasingly important to understand the impact of diabetes on older adults. Hypoglycaemia was the focus at the American Diabetes Association’s 83rd Scientific Ses...

In the latest module from EASD e-Learning, the second in its ‘Lifestyle intervention’ course, Professors Richard Bracken and Dominik Pesta home in on the theory and practice of exercise...